Behavior Imaging®: Resolving Assessment Challenges for Autism Spectrum Disorder in Pharmaceutical Trials

Ron Oberleitner, Uwe Reischl, Kamilla G. Gazieva, N. Nazneen, Jasjit S. Suri, Christopher J. Smith

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Behavior Imaging ® was incorporated into an NIMH-funded multisite pharmaceutical trial to remotely document clinical rater reliability within a standardized observer evaluation protocol. Behavior Imaging provided a centralized telehealth system capable of documenting observer agreement. Interviewer-observer training and ongoing maintenance of assessment quality was performed efficiently. Behavior Imaging provided an important new quality control tool previously not available for such multisite research studies. The results indicate the potential for successful applications also to retrospective studies of archived video data and the evaluation of recorded data obtained in natural settings.

Original languageAmerican English
Title of host publicationAutism Imaging and Devices
StatePublished - 1 Jan 2017

EGS Disciplines

  • Community Health and Preventive Medicine

Fingerprint

Dive into the research topics of 'Behavior Imaging®: Resolving Assessment Challenges for Autism Spectrum Disorder in Pharmaceutical Trials'. Together they form a unique fingerprint.

Cite this